Javier Martin-Broto Selected Research

Javier Martin-Broto Research Topics

Disease

32	Sarcoma (Soft Tissue Sarcoma) 05/2024 - 01/2014
21	Neoplasms (Cancer) 05/2024 - 01/2016
5	Leiomyosarcoma 05/2024 - 01/2020
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 08/2012
3	Solitary Fibrous Tumors 06/2024 - 07/2021
3	Liposarcoma 10/2023 - 08/2021
3	Pain (Aches) 01/2023 - 09/2014
2	Disease Progression 03/2024 - 01/2019
2	COVID-19 01/2024 - 01/2024
2	Myxoid Liposarcoma 01/2023 - 03/2019
2	Aggressive Fibromatosis (Desmoid) 10/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2020
2	Neutropenia 01/2020 - 01/2019
2	Hypertension (High Blood Pressure) 01/2019 - 01/2019
2	Giant Cell Tumor of Bone 12/2017 - 09/2014
2	Synovial Sarcoma (Synovioma) 01/2016 - 01/2014
1	Carcinogenesis 06/2024
1	Tertiary Lymphoid Structures 05/2024
1	Necrosis 01/2024
1	Nausea 01/2022
1	Fatigue 01/2022
1	Infections 03/2019
1	Sepsis (Septicemia) 03/2019
1	Extraskeletal Myxoid Chondrosarcoma 01/2019
1	Myxoma (Myxomas) 01/2019
1	Alveolar Soft Part Sarcoma 01/2018
1	Chordoma 12/2017
1	Osteosarcoma (Osteogenic Sarcoma) 12/2017
1	Breast Neoplasms (Breast Cancer) 10/2016
1	Carcinoma (Carcinomatosis) 10/2016
1	Hematologic Neoplasms (Hematological Malignancy) 10/2016
1	Pigmented Villonodular Synovitis 01/2016

Drug/Important Bio-Agent (IBA)

12	TrabectedinIBA 05/2024 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2016
4	Imatinib Mesylate (Gleevec)FDA Link 10/2023 - 09/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 06/2024 - 04/2018
3	AnthracyclinesIBA 12/2021 - 01/2019
3	Ifosfamide FDA LinkGeneric 12/2021 - 01/2020
3	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 06/2023 - 07/2021
2	selinexorIBA 01/2022 - 08/2021
2	multidrug resistance-associated protein 1IBA 12/2021 - 01/2014
2	nilotinib FDA Link 12/2021 - 11/2018
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 08/2012
2	pazopanib FDA Link 01/2019 - 01/2018
2	Denosumab FDA Link 12/2017 - 09/2014
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016 - 08/2012
1	Carrier Proteins (Binding Protein)IBA 06/2024
1	DNA (Deoxyribonucleic Acid)IBA 06/2024
1	Antisense OligonucleotidesIBA 06/2024
1	Sirolimus (Rapamycin)FDA Link 05/2024
1	ChromatinIBA 05/2024
1	MTOR InhibitorsIBA 05/2024
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2024
1	InterferonsIBA 01/2024
1	ChemokinesIBA 01/2024
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2024
1	CytokinesIBA 01/2024
1	palbociclibIBA 10/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2023
1	Messenger RNA (mRNA)IBA 10/2023
1	regorafenibIBA 01/2023
1	130-nm albumin-bound paclitaxelIBA 10/2022
1	ripretinibIBA 12/2021
1	AZD 6244IBA 12/2021
1	avapritinibIBA 12/2021
1	STAT6 Transcription FactorIBA 07/2021
1	NFI Transcription FactorsIBA 07/2021
1	N 30IBA 12/2020
1	Sunitinib (Sutent)FDA Link 11/2020
1	Immune Checkpoint InhibitorsIBA 11/2020
1	NivolumabIBA 11/2020
1	MicroRNAs (MicroRNA)IBA 10/2020
1	ParaffinIBA 10/2020
1	AlkaloidsIBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	olaratumabIBA 01/2020
1	Hormones (Hormone)IBA 01/2019
1	BilirubinIBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2019
1	Aromatase InhibitorsIBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2016
1	Bortezomib (Velcade)FDA Link 10/2016
1	Macrophage Colony-Stimulating FactorIBA 01/2016
1	Immunomodulating AgentsIBA 01/2016
1	Analgesics (Analgesic Drugs)IBA 09/2014

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 03/2024 - 01/2014
10	Therapeutics 03/2024 - 01/2016
9	Radiotherapy 01/2024 - 01/2016
4	Neoadjuvant Therapy 01/2024 - 01/2021
1	Aftercare (After-Treatment) 12/2022
1	Catheters 03/2019
1	Immunotherapy 01/2016
1	Adjuvant Chemotherapy 01/2014